We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$241M
Cap. Flow
+$165M
Cap. Flow %
14.83%
Top 10 Hldgs %
82.42%
Holding
146
New
26
Increased
26
Reduced
42
Closed
31

Sector Composition

Rank Sector Weight
1 Healthcare 8.54%
2 Energy 1.96%
3 Technology 0.45%
4 Financials 0.44%
5 Real Estate 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
26
Madrigal Pharmaceuticals
MDGL
$12.8B
$3.31M 0.3%
14,294
OCSL icon
27
Oaktree Specialty Lending
OCSL
$1.07B
$3.3M 0.3%
161,510
-26,145
-14% -$516K
MTBA icon
28
Simplify MBS ETF
MTBA
$1.54B
$3.22M 0.29%
+62,332
New +$3.18M
TSAT icon
29
Telesat
TSAT
$554M
$3.03M 0.27%
290,781
+30,000
+12% +$335K
HIGH icon
30
Simplify Enhanced Income ETF
HIGH
$70.3M
$2.96M 0.27%
120,364
+103,893
+631% +$2.57M
TMO icon
31
Thermo Fisher Scientific
TMO
$198B
$2.6M 0.23%
4,897
+3,182
+186% +$1.54M
DAWN
32
DELISTED
Day One Biopharmaceuticals
DAWN
$2.56M 0.23%
175,018
SPQ
33
DELISTED
Simplify US Equity PLUS QIS ETF
SPQ
$2.54M 0.23%
+96,002
New +$2.5M
HUM icon
34
Humana
HUM
$48B
$2.45M 0.22%
5,357
+3,562
+198% +$1.76M
MRK icon
35
Merck
MRK
$315B
$2.42M 0.22%
22,189
+3,402
+18% +$353K
LLY icon
36
Eli Lilly
LLY
$1.05T
$2.42M 0.22%
4,149
-766
-16% -$447K
JNJ icon
37
Johnson & Johnson
JNJ
$609B
$2.35M 0.21%
15,008
-1,157
-7% -$177K
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.82B
$2.29M 0.21%
+23,715
New +$2.27M
MDT icon
39
Medtronic
MDT
$106B
$2.26M 0.2%
27,456
-2,010
-7% -$153K
PHAT icon
40
Phathom Pharmaceuticals
PHAT
$873M
$2.17M 0.19%
237,935
ARDX icon
41
Ardelyx
ARDX
$1.28B
$2.17M 0.19%
+350,000
New +$1.57M
BSV icon
42
Vanguard Short-Term Bond ETF
BSV
$44.7B
$2.13M 0.19%
27,712
IBDP
43
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$2.13M 0.19%
+85,442
New +$2.12M
MIRM icon
44
Mirum Pharmaceuticals
MIRM
$7.25B
$2.07M 0.19%
70,000
IAU icon
45
iShares Gold Trust
IAU
$62.4B
$1.9M 0.17%
48,714
-5,514
-10% -$206K
UNH icon
46
UnitedHealth
UNH
$387B
$1.85M 0.17%
3,511
-1,274
-27% -$679K
ISRG icon
47
Intuitive Surgical
ISRG
$122B
$1.84M 0.17%
5,467
-1,954
-26% -$582K
DAL icon
48
PUT
Delta Air Lines
DAL
$55.4B
$1.82M 0.16%
45,000
+20,000
+80% +$725K
CYTK icon
49
Cytokinetics
CYTK
$10.9B
$1.82M 0.16%
+21,797
New +$789K
NLY icon
50
Annaly Capital Management
NLY
$16.9B
$1.81M 0.16%
93,200
+61,000
+189% +$1.09M

Similar funds

Simplify Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Simplify Asset Management held 146 positions worth $1.12B, up 28% from $875M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Simplify Asset Management deployed $165M of net new capital in Q4 2023, opening 26 new positions and adding to 26 existing holdings. Its largest new stake was Simplify Stable Income ETF: 1,069,370 shares worth $26.7M.

By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, down from 11% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $29.8M trimmed.

  • Simplify Asset Management's largest Q4 2023 buy was Simplify Stable Income ETF: 1,069,370 shares worth $26.7M.
  • Simplify Asset Management added most to Simplify Aggregate Bond ETF in Q4 2023, an estimated $47.6M increase.
  • Simplify Asset Management's biggest Q4 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $29.8M.
  • Simplify Asset Management fully exited iShares Core MSCI EAFE ETF in Q4 2023, selling an estimated $15.3M.
  • Simplify Asset Management's ten largest holdings make up 82% of its $1.12B portfolio in Q4 2023.
  • Simplify Asset Management opened 26 new positions and closed 31 in Q4 2023.
  • Simplify Asset Management's portfolio value rose 28% quarter-over-quarter to $1.12B.

Based on Simplify Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.